Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study

Author:

Boender T. Sonia12,Sigaloff Kim C. E.12,Kayiwa Joshua3,Musiime Victor3,Calis Job C. J.4,Hamers Raph L.12,Nakatudde Lillian Katumba3,Khauda Elizabeth3,Mukuye Andrew5,Ditai James6,Geelen Sibyl P.7,Mugyenyi Peter3,Rinke de Wit Tobias F.12,Kityo Cissy3

Affiliation:

1. PharmAccess Foundation, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands

2. Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam Institute for Global Health and Development, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands

3. Joint Clinical Research Centre, Plot No. 101 Lubowa Hill, P.O. Box 10005, Kampala, Uganda

4. Global Child Health Group, Emma Children’s Hospital, Academic Medical Center of the University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands

5. Joint Clinical Research Centre, Pallisa Road, Mbale, P.O. Box 10005, Kampala, Uganda

6. Joint Clinical Research Centre, Kamwenge Road, Fort Portal, P.O. Box 10005, Kampala, Uganda

7. Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands

Abstract

Although the advantages of early infant HIV diagnosis and treatment initiation are well established, children often present late to HIV programs in resource-limited settings. We aimed to assess factors related to the timing of treatment initiation among HIV-infected children attending three clinical sites in Uganda. Clinical and demographic determinants associated with early disease (WHO clinical stages 1-2) or late disease (stages 3-4) stage at presentation were assessed using multilevel logistic regression. Additionally, semistructured interviews with caregivers and health workers were conducted to qualitatively explore determinants of late disease stage at presentation. Of 306 children initiating first-line regimens, 72% presented late. Risk factors for late presentation were age below 2 years old (OR 2.83,P=0.014), living without parents (OR 3.93,P=0.002), unemployment of the caregiver (OR 4.26,P=0.001), lack of perinatal HIV prophylaxis (OR 5.66,P=0.028), and high transportation costs to the clinic (OR 2.51,P=0.072). Forty-nine interviews were conducted, confirming the identified risk factors and additionally pointing to inconsistent referral from perinatal care, caregivers’ unawareness of HIV symptoms, fear, and stigma as important barriers. The problem of late disease at presentation requires a multifactorial approach, addressing both health system and individual-level factors.

Funder

European and Developing Countries Clinical Trials Partnership

Publisher

Hindawi Limited

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Dermatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3